Suzanne Louise Bruhn - Nov 10, 2021 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
Director
Signature
/s/ Christopher R. Sullivan, by Power of Attorney
Stock symbol
AVTX
Transactions as of
Nov 10, 2021
Transactions value $
$0
Form type
4
Date filed
11/12/2021, 03:03 PM
Previous filing
Oct 4, 2021
Next filing
May 12, 2022

Suzanne Louise Bruhn is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Remarks:

The reporting person resigned as a director of Avalo Therapeutics, Inc. effective November 10, 2021. As a result, the reporting person is no longer subject to Section 16 in connection with her transactions in the equity securities of Avalo Therapeutics, Inc. and therefore will no longer report any such transactions on Form 4 or Form 5.